Laser Treatment of Reticular Leg Veins vs. Sclerotherapy
ConditionReticular Leg Veins
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorDerzhavin Tambov State University
About this trial
Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.
Eligibility criteria
Qualifiers
women over 18
reticular veins
signed informed consent to participate in the study
Disqualifiers
diabetes mellitus
pregnancy or lactation
malignant neoplasms
inability or unwillingness of the patient to wear compression stockings
Trial design
Treatments tested in this trial
- Laser ablation
- Laser with Sclerotherapy
- Sclerotherapy
Treatment groups
174 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov